Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Credit Facility

30 Apr 2012 09:00

RNS Number : 3248C
J.P. Morgan Private Equity Ltd
30 April 2012
 



 

 

 

JPEL ANNOUNCES in principle agreement for

EXTENSION OF $150 Million MULTI-CURRENCY CREDIT FACILITYWITH LLOYDS BANK CORPORATE MARKETS

 

* * *

 

GUERNSEY, 30 APRIL 2012

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce that it has agreed in principle to terms on a new multi-currency credit facility with a longer maturity date with Lloyds TSB Bank plc.

 

The new facility will expire in January 2017 and contains similar covenants to the Company's existing $150 million multi-currency facility which was due to expire in May 2013. Key terms of the proposed facility include:

 

·; LIBOR +280bps for a loan to value ratio (LTV) of less than or equal to 10%, with no LIBOR floor

·; LIBOR +330bps for a LTV ratio of greater than 10%, with no LIBOR floor

 

"We continue focus on the optimization of our capital structure." said Trevor Ash, JPEL's Chairman. "This proposed facility will provide JPEL with increased financial flexibility to support its strategic initiatives over the next several years."

 

"Moreover, extending the credit facility in 2017 will be an important milestone for JPEL. The Directors believe that the proposed refinancing will benefit the Company by allowing JPEL to focus on creating shareholder value while simultaneously representing the first step to clarifying the long-term capital structure" added Mr. Ash added.

 

The amended and extended credit facility is subject to final documentation and is currently expected to be completed in May. Furthermore, the Company anticipates that it will hold its annual general meeting on or about the end of June with materials available to shareholders on or about the end of May.

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 3032 / +1 212 648 1150

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

Peregrine Communications

Anthony Payne / Max Hilton

+44 203 178 6869

anthony.payne@peregrinecommunications.com / max.hilton@peregrinecommunications.com

 

For Lloyds Bank Corporate Markets

Louise Riordan

Financial Dynamics

+ 44 (0)20 7269 9308 / 07515 597 556

louise.riordan@fd.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKKDQOBKKFQN
Date   Source Headline
14th Mar 20143:33 pmRNSNet Asset Value(s) and Monthly Report January 2014
26th Feb 20144:11 pmRNSHalf Yearly Report
11th Feb 20145:40 pmRNSMonthly Report - December 2013
11th Feb 20145:31 pmRNSNet Asset Value(s)
6th Feb 20145:09 pmRNSAppointment of Joint Corporate Broker
17th Jan 20145:47 pmRNSHolding(s) in Company
17th Jan 20144:39 pmRNSHolding(s) in Company
16th Jan 20146:06 pmRNSHolding(s) in Company
16th Jan 20146:05 pmRNSHolding(s) in Company
16th Jan 20145:56 pmRNSHolding(s) in Company
15th Jan 20147:00 amRNSStrategic Update
30th Dec 20135:11 pmRNSMonthly Report - November 2013
30th Dec 20135:08 pmRNSNet Asset Value(s)
5th Dec 201312:10 pmRNSMonthly Report - October 2013
5th Dec 201311:58 amRNSNet Asset Value(s)
26th Nov 20133:02 pmRNSHolding(s) in Company
25th Nov 20135:03 pmRNSHolding(s) in Company
20th Nov 20135:17 pmRNSHolding(s) in Company
20th Nov 20135:14 pmRNSHolding(s) in Company
13th Nov 20134:49 pmRNSMonthly Report - September 2013
13th Nov 20134:47 pmRNSNet Asset Value(s)
12th Nov 20135:39 pmRNSHolding(s) in Company
17th Oct 20134:46 pmRNSAnnual Financial Report
11th Oct 20135:01 pmRNSMonthly Report - August 2013
11th Oct 20134:50 pmRNSNet Asset Value(s)
18th Sep 20134:01 pmRNSMonthly Report - July 2013
18th Sep 20134:00 pmRNSNet Asset Value(s)
28th Aug 20135:20 pmRNSDirector Declaration
12th Aug 20136:12 pmRNSMonthly Report - June 2013
12th Aug 20135:52 pmRNSNet Asset Value(s)
11th Jul 20136:10 pmRNSAGM Circular
8th Jul 20135:15 pmRNSTR-1
1st Jul 20132:03 pmRNSMonthly Report - May 2013
1st Jul 20131:54 pmRNSNet Asset Value(s)
27th Jun 201310:25 amRNSStrategic Initiatives Update
14th Jun 20134:35 pmRNSNet Asset Value(s)
14th Jun 20134:20 pmRNSMonthly Report - April 2013
13th Jun 20136:26 pmRNSAGM Circular
22nd May 20135:05 pmRNSNet Asset Value(s)
22nd May 20135:01 pmRNSMonthly Report - March 2013
7th May 20137:00 amRNSRetirement of 2013 Zero Dividend Preference Shares
2nd May 20133:42 pmRNSHolding(s) in Company
15th Apr 201312:30 pmRNSTiming of retirement of 2013 ZDP Shares
2nd Apr 20134:59 pmRNSMonthly Report - February 2013
2nd Apr 20134:57 pmRNSNet Asset Value(s)
6th Mar 20139:53 amRNSNet Asset Value(s)
6th Mar 20139:46 amRNSMonthly Report - January 2013
28th Feb 20135:38 pmRNSHalf Yearly Report
27th Feb 20135:07 pmRNSInitial Sale of Non-Core Assets
8th Feb 20135:46 pmRNSMonthly Report - December 2012

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.